Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human critical leg ischemia.

Ho TK, Tsui J, Xu S, Leoni P, Abraham DJ, Baker DM.

J Vasc Surg. 2010 Mar;51(3):689-99. doi: 10.1016/j.jvs.2009.10.044.

2.

Toll-like receptor 2-blocking antibodies promote angiogenesis and induce ERK1/2 and AKT signaling via CXCR4 in endothelial cells.

Wagner NM, Bierhansl L, Nöldge-Schomburg G, Vollmar B, Roesner JP.

Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1943-51. doi: 10.1161/ATVBAHA.113.301783. Epub 2013 May 30.

3.

LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.

Wu M, Chen Q, Li D, Li X, Li X, Huang C, Tang Y, Zhou Y, Wang D, Tang K, Cao L, Shen S, Li G.

J Cell Biochem. 2008 Jan 1;103(1):245-55.

PMID:
17549698
4.

Stromal cell-derived factor-1/CXCR4 promotes IL-6 production in human synovial fibroblasts.

Chen HT, Tsou HK, Hsu CJ, Tsai CH, Kao CH, Fong YC, Tang CH.

J Cell Biochem. 2011 Apr;112(4):1219-27. doi: 10.1002/jcb.23043.

PMID:
21312239
5.

Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.

Yu JX, Huang XF, Lv WM, Ye CS, Peng XZ, Zhang H, Xiao LB, Wang SM.

J Vasc Surg. 2009 Sep;50(3):608-16. doi: 10.1016/j.jvs.2009.05.049. Epub 2009 Jul 12.

6.

Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways.

Shen X, Artinyan A, Jackson D, Thomas RM, Lowy AM, Kim J.

Pancreas. 2010 Jan;39(1):81-7. doi: 10.1097/MPA.0b013e3181bb2ab7.

PMID:
19820417
7.

Expression of vascular endothelial growth factor, stromal cell-derived factor-1, and CXCR4 in human limb muscle with acute and chronic ischemia.

van Weel V, Seghers L, de Vries MR, Kuiper EJ, Schlingemann RO, Bajema IM, Lindeman JH, Delis-van Diemen PM, van Hinsbergh VW, van Bockel JH, Quax PH.

Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1426-32. Epub 2007 Mar 15.

8.

Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis.

Fukuda S, Broxmeyer HE, Pelus LM.

Blood. 2005 Apr 15;105(8):3117-26. Epub 2004 Dec 23.

9.

The SDF-1α/CXCR4 axis is required for proliferation and maturation of human fetal pancreatic endocrine progenitor cells.

Kayali AG, Lopez AD, Hao E, Hinton A, Hayek A, King CC.

PLoS One. 2012;7(6):e38721. doi: 10.1371/journal.pone.0038721. Epub 2012 Jun 22.

10.
11.

Curcumin modulates SDF-1alpha/CXCR4-induced migration of human retinal endothelial cells (HRECs).

Sameermahmood Z, Balasubramanyam M, Saravanan T, Rema M.

Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3305-11. doi: 10.1167/iovs.07-0456.

PMID:
18660423
12.

Transfusion of CXCR4-primed endothelial progenitor cells reduces cerebral ischemic damage and promotes repair in db/db diabetic mice.

Chen J, Chen J, Chen S, Zhang C, Zhang L, Xiao X, Das A, Zhao Y, Yuan B, Morris M, Zhao B, Chen Y.

PLoS One. 2012;7(11):e50105. doi: 10.1371/journal.pone.0050105. Epub 2012 Nov 21.

13.

Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.

Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, Bridger G, Balkwill FR.

Cancer Res. 2002 Oct 15;62(20):5930-8.

14.

Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells.

Peng SB, Peek V, Zhai Y, Paul DC, Lou Q, Xia X, Eessalu T, Kohn W, Tang S.

Mol Cancer Res. 2005 Apr;3(4):227-36.

15.

Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway.

Chu CY, Cha ST, Lin WC, Lu PH, Tan CT, Chang CC, Lin BR, Jee SH, Kuo ML.

Carcinogenesis. 2009 Feb;30(2):205-13. doi: 10.1093/carcin/bgn228. Epub 2008 Oct 9.

16.

A novel CXCR4 antagonist derived from human SDF-1beta enhances angiogenesis in ischaemic mice.

Tan Y, Li Y, Xiao J, Shao H, Ding C, Arteel GE, Webster KA, Yan J, Yu H, Cai L, Li X.

Cardiovasc Res. 2009 Jun 1;82(3):513-21. doi: 10.1093/cvr/cvp044. Epub 2009 Feb 5.

17.

Increased endogenous angiogenic response and hypoxia-inducible factor-1alpha in human critical limb ischemia.

Ho TK, Rajkumar V, Ponticos M, Leoni P, Black DC, Abraham DJ, Baker DM.

J Vasc Surg. 2006 Jan;43(1):125-33.

18.

Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis.

Badr G, Lefevre EA, Mohany M.

PLoS One. 2011;6(9):e23741. doi: 10.1371/journal.pone.0023741. Epub 2011 Sep 1.

19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk